about
The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota.Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models.Changes in genital tract immune cell populations after initiation of intrauterine contraception.Acceptability of randomization to levonorgestrel versus copper intrauterine device among women requesting IUD insertion for contraception.Prevention of infection after induced abortion: release date October 2010: SFP guideline 20102.Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis.Polyherbal formulations with wide spectrum antimicrobial activity against reproductive tract infections and sexually transmitted pathogens.Examining intendedness among pregnancies ending in spontaneous abortion.Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy.Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals?Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment.Misreporting of contraceptive hormone use in clinical research participants.Self-Administered Lidocaine Gel for Intrauterine Device Insertion in Nulliparous Women: A Randomized Controlled Trial.Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?Synthetic osmotic dilators with adjunctive misoprostol for same-day dilation and evacuation: a randomized controlled trial.Family Planning and Counseling Desires of Women Who Have Experienced Miscarriage.Impact of contraceptive initiation on vaginal microbiota.Hormonal contraceptive methods and HIV: research gaps and programmatic priorities.Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in womenProbing the stability of class I major histocompatibility complex (MHC) molecules on the surface of human cellsEndometrial plasma cells: do they indicate subclinical pelvic inflammatory disease?Transvaginal administration of intraamniotic digoxin prior to dilation and evacuationImpact of etonogestrel implant use on T-cell and cytokine profiles in the female genital tract and bloodA sensitive and robust UPLC-MS/MS method for quantitation of estrogens and progestogens in human serumDepot medroxyprogesterone acetate and norethisterone enanthate differentially impact T-cell responses and expression of immunosuppressive markersOptimization of processing female genital tissue samples for lymphocyte analysis by flow cytometry
P50
Q27692596-33D82758-332A-4F9F-B587-3B789B564C71Q34084281-3853E6FB-9143-4165-B17B-E829E78FC39FQ34506212-D39B9964-0A71-4643-9178-08B5D6A8E3DCQ36303502-5A1AA538-D202-458E-843E-A2BD633503D3Q37851208-4E19BB13-0CE9-4FE9-942E-D5C61C991C41Q37870801-EFD827A2-C0E8-4076-A896-1EEA528A32C5Q37876809-59ED85CC-0771-4728-91B3-71BDFB6374A4Q38675200-22448125-B63F-4530-A7CA-8DACB6050339Q38686382-3268D3EB-D02B-4497-B4C7-694E67D0FBE4Q40515915-2C496628-8411-4ADF-B91E-0E3DDFF4122EQ40530461-81E95C8C-8823-4B98-A459-9CA1D7318923Q46010525-D07C89BF-1E12-492A-81E2-E6BC096A84BCQ46185924-03042090-18EA-4DDD-B24A-F206AD13D557Q49838895-41BC0A30-C881-4D93-BD15-4699C32431B2Q51755959-9B904E73-D8CA-46A8-B082-CD0BD5DC59B8Q52660842-82F57FDA-3774-4C65-A685-81C5890DA2D6Q53700728-32A1C1AC-B255-48E5-9E0B-C2F9C5229507Q53728030-77466B2D-1F1E-4F41-8327-D4BEA688B349Q64090731-BD3EB241-122E-4F47-A46C-E1FC76C9CE69Q73334882-FE05D59A-6A29-4A37-8DC7-789D1168DC22Q81436174-E0F9FA3D-1C1D-4914-A6A2-B0DD149177ADQ84949831-92AA70C6-24E4-425A-AE32-A73563C0B35AQ90665820-4E2DA510-8DD3-440A-A67B-939C1D23C9CAQ91236505-997AD81E-2EF6-4C51-83FB-96B79D5DAE80Q91290609-8AE8C3F9-7F4F-4830-8675-898962FC46E7Q92996515-0025B07E-A712-4341-976B-1923837C4A96
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sharon L Achilles
@ast
Sharon L Achilles
@en
Sharon L Achilles
@es
Sharon L Achilles
@nl
Sharon L Achilles
@sl
type
label
Sharon L Achilles
@ast
Sharon L Achilles
@en
Sharon L Achilles
@es
Sharon L Achilles
@nl
Sharon L Achilles
@sl
prefLabel
Sharon L Achilles
@ast
Sharon L Achilles
@en
Sharon L Achilles
@es
Sharon L Achilles
@nl
Sharon L Achilles
@sl
P106
P31
P496
0000-0002-7478-8262